Skip to main content

Table 4 Number of drugs per PWAD and polypharmacy. Median (1st-3rd quartile); Differences in regard to age group, living situation, sex, and symptom onset

From: A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia

  

Median number of drugs received

p-value

(MWU)

Proportion of polypharmacy (≥5 drugs)

p-value

(CHI2)

Total sample

N=191

4 (2-6)

 

n=95; 50%

 

Age

<65 years

n=38; 20%

3 (2-5)

0.011*

n=13; 34%

0.032*

≥65 years

n=153; 80%

5 (3-7)

n=82; 54%

Living Situation

HC

n=88; 46%

4 (2-6)

0.001*

n=32; 36%

0.001*

LTC

n=103; 54%

5 (4-7)

n=63; 61%

Sex

female

n=106; 56%

5 (2-6)

0.480

n=57; 54%

0.213

male

n=85; 44%

4 (2-6)

n=38; 45%

Dementia onset

YOD

n=93; 49%

4 (2-6)

0.068

n=42; 45%

0.218

LOD

n=98; 51%

5 (3-7)

n=53; 54%

  1. CHI2 chi square test, HC home care, LTC long term care, LOD late onset dementia, MWU Mann-Whitney-U test, YOD young onset dementia, * difference statistically significant